Dr. Ruth McPherson is Director of the Ruddy Canadian Cardiovascular Genetics CentreAtherogenomics Laboratory and the Lipid Clinic, and Director of Research for the Division of Cardiology at the University of Ottawa Heart Institute. She is also a Professor in the Departments of Medicine and Biochemistry at the University of Ottawa.


Dr. McPherson received her PhD from the University of London, in England, and her MD from the University of Toronto, where she graduated magna cum laude in 1984. She completed subspecialty training in Internal Medicine and Endocrinology and Metabolism at the University of Toronto. She held academic positions at the University of Toronto and McGill University in Montreal before coming to the University of Ottawa Heart Institute in 1992.   

Dr. McPherson is a key opinion leader in Canada in the area of clinical lipidology and cardiovascular risk reduction. She is an author on the recent Canadian Cardiovascular Society Position Statement on the Diagnosis and Treatment of Dyslipidemia and Prevention of Cardiovascular Disease and has been a strong advocate of strategies for the primary and secondary prevention of cardiovascular disease. She is a leader in cardiovascular genetics, having led the discovery of the 9p21 genetic risk factor for heart disease in 2007.

Dr. McPherson is funded by the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada. She has published over 180 manuscripts in peer-reviewed journals. She currently holds the Merck Frosst Canada Chair in Atherosclerosis. Dr. McPherson is Associate Editor of Arteriosclerosis, Thrombosis, and Vascular Biology.  She was elected a fellow of the Royal Society of Canada in 2014.